Monitor for additional draws under the up-to-$1.5M facility and any subsequent equity or debt issuance. The note covenants limit senior debt and dividends, signaling potential near-term cash needs. No financial results or guidance were provided; next quarterly report will clarify operating trajectory.
Price Chart
Executive Summary
Elite Health Systems secured $525,000 in bridge financing from its CEO and chair via an unsecured subordinated note due July 31, 2027, bearing 10% annual interest, with a warrant to purchase up to 110,526 shares at $0.95 through July 31, 2031. The agreement also permits up to $1.5 million in total additional investment on the same terms. While insider funding signals CEO commitment, the debt adds interest expense and potential dilution from the warrant, making the overall read mixed.
Key Financial Metrics
Key Facts
- Company entered $525,000 subordinated note and warrant agreement with CEO and chair Dr. Prasad Jeereddi on July 31, 2026.
- Note carries 10% simple annual interest, matures July 31, 2027, unsecured, with 2% prepayment penalty after six months.
- Warrant to purchase 110,526 shares at $0.95 per share, exercisable for five years (through July 31, 2031), includes cashless exercise feature.
- Warrant shares not registered; warrant coverage equals 20% of the note principal (approximately $105,000 notional).
- Up to $1.5 million aggregate additional investment may be accepted under same terms.
- Note restricts incurrence of senior debt, granting senior liens, dividends, and share repurchases without holder consent.
Financial Impact
$525,000 principal added to debt, plus up to 110,526 potential dilutive shares at $0.95 exercise price.
Risk Factors
- Default on the note (cure period of 10 business days) could trigger acceleration of full principal.
- Warrant exercise at $0.95 per share could dilute existing shareholders if shares are issued at a discount to market.
- Related-party transaction may create governance concerns; note covenants restrict financial flexibility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (EHSI) — Batch item 1 | 0001437749-26-025897 |
| Exhibit: ex_999455.htm | 0001437749-26-025897 |
| Exhibit: ex_999456.htm | 0001437749-26-025897 |
| Document: 0001437749-26-025897-index-headers.html | 0001437749-26-025897 |
| Document: 0001437749-26-025897-index.html | 0001437749-26-025897 |
| Document: 0001437749-26-025897.txt | 0001437749-26-025897 |
| 8-K Filing (EHSI) — Batch item 7 | 0001437749-26-025897 |
| Exhibit: ex_999455.htm | 0001437749-26-025897 |
| Exhibit: ex_999456.htm | 0001437749-26-025897 |
| Document: 0001437749-26-025897-index-headers.html | 0001437749-26-025897 |
| Document: 0001437749-26-025897-index.html | 0001437749-26-025897 |
| Document: 0001437749-26-025897.txt | 0001437749-26-025897 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 11w ago | 8-K | $1.00 | awaiting T+60 | — | $0.8300 (−17.00%) |
Jul 10, 2026 15w ago | 8-K | $1.01 $0.7000 | ▲ +30.69% | ▲ +33.58% | $0.8300 (+17.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers